ArticleCancers2013

Role of Hydroxamate-Based Histone Deacetylase Inhibitors (Hb-HDACIs) in the Treatment of Solid Malignancies.

Antonino Grassadonia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.